Russell Investments Group, Ltd. Cti Biopharma Corp Transaction History

Russell Investments Group, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$5.36 - $7.43 $1.92 Million - $2.65 Million	357,303 New	357,303 $2.08 Million
Q3 2018 Oct 26, 2018	SELL	$1.72 - $5.24 $15,732 - $47,930	-9,147 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$3.81 - $5.26 $34,850 - $48,113	9,147 New	9,147 $46,000
Q1 2018 May 11, 2018	SELL	$2.7 - $4.06 $87,258 - $131,211	-32,318 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$2.47 - $3.34 $79,825 - $107,942	32,318	32,318 $86,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.